The many faces of FcγRI: implications for therapeutic antibody function.
about
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Modulation of Microglial Cell Fcγ Receptor Expression Following Viral Brain Infection.The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model.FcεRI γ-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells.A generalized quantitative antibody homeostasis model: maintenance of global antibody equilibrium by effector functions.Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection.
P2860
Q33913839-A2AC50A2-E544-4325-9D2B-BC51AF4835A7Q37114367-C6C5BBAF-243B-4FD4-A31C-993097032AC5Q37626070-2899D2E4-1F2F-4E51-89A0-86CFC68960E0Q38615370-ABA4AC78-FEBE-4282-A798-D11450621ADAQ38760836-DEB411E7-5A63-47D1-8014-764F33B513CEQ45365480-E6FC47D0-8DFE-4A05-BCA6-658878D1EAE0Q47117902-8D90A2DF-9522-41B8-A65C-83207279973FQ47146176-407EFAF9-BEBE-4336-A00A-249F6FD878FD
P2860
The many faces of FcγRI: implications for therapeutic antibody function.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The many faces of FcγRI: implications for therapeutic antibody function.
@en
type
label
The many faces of FcγRI: implications for therapeutic antibody function.
@en
prefLabel
The many faces of FcγRI: implications for therapeutic antibody function.
@en
P2860
P356
P1476
The many faces of FcγRI: implications for therapeutic antibody function.
@en
P2093
Gerald M Feldman
Jennifer F A Swisher
P2860
P304
P356
10.1111/IMR.12334
P577
2015-11-01T00:00:00Z